CEITEC ICRC BIOCEV

621 views
536 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
621
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

CEITEC ICRC BIOCEV

  1. 1. 129/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC – Central European Institute of Technology Mgr. Tomáš Hruda
  2. 2. 229/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC – Central European Institute of Technology Location: Brno, South Moravian Region Vision: Establish a Centre of Excellence conducting research in the area of Quality of Life and Human Health. Funding: structural funds - Operational program R&D for Innovation 2007- 2013, already selected for the Indicative list of projects, app. 320 mil. EUR. Schedule: 2009 – full call for proposals 2010 – project approval (both CZ and European Commission) 2010-2014 – construction and acquisition of equipment
  3. 3. 329/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC – Why Brno as a location? 32 % of public R&D spending (without Prague). 3.000 researchers in engineering and life science. Wide range of research facilities. Long history of technology and medical research development and production. 6 public universities with 80.000+ students. Clear & functional regional innovation strategy.
  4. 4. 429/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC – strong team of partners Masaryk University Brno University of Technology Mendel University of Agriculture and Forestry University of Veterinary and Pharmaceutical Sciences Institutes of the Academy of Sciences of the Czech Republic: Institute of Biophysics, Institute of Scientific Instruments, Institute of Analytical Chemistry, Institute of Physics of Materials Veterinary Research Institute … bundling together best research groups of Southern Moravia accross institutions
  5. 5. 529/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC – research programmes blending Life Sciences and Advanced Materials and Technologies Structural biology and molecular biophysics Cell and molecular biology of model systems Applied neuroscience and molecular medicine Advanced biomedical modelling and veterinary science Advanced materials Advanced nano- and micro- technologies Biomedical technologies Advanced communicati on & IT CEITEC
  6. 6. 629/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC – Central European Institute of Technology Main principles: Clear focus (Quality of Life and Human Health), vision (scientific excellence) and corresponding managerial structure. Transparent and effective rules for cooperation with the private sector. Openness to excellent scientists (Czech or foreign). Connecting to Europe - ESFRI: to be associated to large scale EU research infrastructures INSTRUCT (structural biology) and PRINS (nanostructures).
  7. 7. 729/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC Contacts CEITEC – Central European Institute of Technology Žerotínovo nám. 9 601 77 Brno Czech Republic E-mail: info@ceitec.cz Web: www.ceitec.eu Project director Tomáš Hruda, tomas.hruda@ceitec.cz
  8. 8. 829/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC Cluster Bioinformatics Ing. Stanislav Mrázek
  9. 9. 929/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC Cluster Bioinformatics Main Activities Marketing Human Resources Consultancy CEITEC Cluster Bioinformatics associates commercial companies and research institutes both public and private. Main objective of cluster is to foster mutual collaboration in order to increase competitive advantage of the members. Ideas Exchange CEITEC Project Joint Research Projects
  10. 10. 1029/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC Cluster Bioinformatics Members Bio-Vendor, Laboratory medicine a.s. Camea s.r.o. Eco – Management s.r.o. Enantis s.r.o. Elisabeth Pharmacom s.r.o. Favea s.r.o. FEI Czech Republic s.r.o. South Moravian Center for International Mobility MAC s.r.o. Tescan s.r.o. Textilní zkušební ústav Výzkumný ústav pletařský Masaryk Univerzity Biophysical Institute Academy of Science FTM Communications, s.r.o.
  11. 11. 1129/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC Cluster Bioinformatics Members Jihočeská agentura pro podporu inovativního podnikání o.p.s. South Moravian Regional Development Agency ENVISAN-GEM a.s. STROKOM, s.r.o. NETS.CZ, s.r.o. HDT s.r.o. Enzymo Plus s.r.o. GEN - TREND s.r.o. Vidia spol. s r.o. Center of Cardiovascular and transplantation Surgery
  12. 12. 1229/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CEITEC Cluster Bioinformatics Contacts Address: U Vodárny 2, 616 00, Brno, Czech Republic Mobil: + 420 608 022 220 E-mail: info@ceitec-cluster.cz www.ceitec-cluster.cz
  13. 13. 1329/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research International Clinical Research Center Brno MUDr. Tomáš Kára, PhD.
  14. 14. 1429/01/15 International Clinical Research Center Brno Location: St. Anne’s University Hospital Brno. Mission: Establishing the first international center for applied medical research capable of accelerating research process and knowledge transfer from bench to bedside. Key aspects: Novel concept and logistics of scientific collaboration & strong transatlantic partnership. Strategic U.S. Partner: Mayo Clinic (Rochester, MN, USA) Funding: Approved as strategic project of the Government of the Czech Republic with budget of 80 mil. EUR. Construction expected to be completed in 12/2010. Global position: After CERN and International Space Station, ICRC Brno will be the third international research center sharing identical principles and values with CERN and ISS. Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research
  15. 15. 1529/01/15 ICRC Brno – Science without Borders Key directions: cardiovascular, neurosciences and oncology R&D Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research
  16. 16. 1629/01/15 ICRC Translational research, international collaboration ICRC Brno -- Brno BiotechBrno Biotech PartnershipPartnership TECHNOLOG Y University Campus basic research Animal Res. Center preclinical R&D SYNERGY UT ISI CEITEC TECHNOPA RK BRNO
  17. 17. 1729/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research International Clinical Research Center Brno Contacts: Address:Fakultní nemocnice u sv. Anny, ICRC, Pekařská 53, 656 91, Brno E-mail: info@icrcbrno.org Telephone: + 420 543 181 161 www.icrcbrno.org
  18. 18. 1829/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research BIOCEV - Biotech & Biomed Research Center of Academy of Science and Charles University Ing. Peter Šebo, CsC.
  19. 19. 1929/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Biotech & Biomed Research Center of Academy of Science and Charles University Location: Central Bohemia Region, Vestec u Prahy Main objective: Regional development and competitiveness through promotion of cutting-edge biotechnology and biomedical R&D in Czech Republic. Selected for the Indicative list of projects of the Operationsl program R&D for Innovation European Regional Development Fund 2007 – 2013.
  20. 20. 2029/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Biotech & Biomed Research Centre of Academy of Science and Charles University Budget: 114 mil. € without start-up Main milestones: December 2007 – Consortium agreement February 2008 – BIOCEV registered as a legal entity March 2009 – project submitted to the Ministry of Education of CR October 2010 – construction starts October 2013 – BIOCEV full operation
  21. 21. 2129/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Biotech & Biomed Research Center of Academy of Science and Charles University Activities Graduate education International school of advanced studies in biotechnology and biomedcine Basic research Oriented research Cell culture Protection of itellectual property, technology transfer and bussines development Mouse clinic Structural Biology Imaging
  22. 22. 2229/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Biotech & Biomed Research Center of Academy of Science and Charles University Project coordinator: Ing. Peter Šebo Csc. - sebo@biomed.cas.cz Project secretary: MUDr. Jan Rajnoch – rajnoch@img.cas.cz
  23. 23. 2329/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CzechBio, Association of Biotechnology companies MUDr. Jan Rajnoch
  24. 24. 2429/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research CzechBio, Association of Biotechnology companies Founded 18th Dcember 2008 25 members 1 university 1 public research institute of the Academy of Science
  25. 25. 2529/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Czech Bio, Association of Biotechnology companies Biotech cluster activities: Communication Associative activities Lobbying Joint business development Research collaborations Education of human resources Joint presentations abroad Mingling sessions Interaction with government
  26. 26. 2629/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Czech Bio, Association of Biotechnology companies Founding members: Apronex s.r.o. Ascoprot Biotech s.r.o. BIOFARM, Výzkumný ústav biofarmacie a veterinárních léčiv BioTest s.r.o. BioVendor – Laboratorní medicína a.s. BioVeta a.s. BVT Technologies a.s. CS – Project s.r.o. Enantis s.r.o. Envisan-Gem a.s. EPS s.r.o. Generi Biotech s.r.o. Labina s.r.o. LentiKat‘s a.s. Lonza Biotech s.r.o. Protean s.r.o. Proteix s.r.o. Sevapharma a.s. Top Bio s.r.o. Vidia s.r.o.
  27. 27. 2729/01/15 Forum 4 – Maximizing synergies of FP7, Structural Funds and Collaboration of Academia and Industry for Central European Biotech research Czech Bio, Association of Biotechnology companies Managers MUDr. Jan Rajnoch rajnoch@img.cas.cz Ilona Dita dita@img.cz Seat Nad Safinou II/366, 222 42 Vestec Contact BTÚ, Jan Rajnoch, Vídeňská 1083, 142 20 Praha 4

×